ARQT - Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company is headquartered in Westlake Village, California.

52W High

$17.75

52W Low

$8.03

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.94

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

212.77

EV/EBITDA (<8 favorable)

-2.04

EV/Revenue (<3 favorable)

7.50

P/S (TTM) (<3 favorable)

7.81

P/B (<3 favorable)

14.80

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.94%

Institutions (25–75% balanced)

109.93%

Shares Outstanding

119,905,000

Float

85,575,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

263,465,000

Gross Profit (TTM)

234,735,000

EPS (TTM)

-0.73

Profit Margin (>10% good)

-0.35%

Operating Margin (TTM) (higher better)

-0.18%

ROE (TTM) (>15% strong)

-0.57%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.64

Momentum

Bearish momentum

Value

0.7500

0.7663

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025